MedTrace Logo

Can EmeraldLED Reshape Your Body With Continued Use?

NCT07282119 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-12-23

No results posted yet for this study

Summary

Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition.

Conditions

  • Body Composition

Interventions

DEVICE

EmeraldLED

This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm². The green light EmeraldLED therapy provided in this study is set at 525 nm.

Sponsors & Collaborators

  • Efforia, Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-29
Primary Completion
2026-08-29
Completion
2026-08-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07282119 on ClinicalTrials.gov